APOE and chronic kidney disease: Such a phenomenon can be considered as one of the factors accelerating atherosclerosis development, since it has been shown in both non-CKD and CKD patients that APOE level in APOB-containing lipoproteins positively associates with incident CVD risk [22, 42].